Arsenic is usually thought of as a poison. Despite this, it has been used in medicine for over 2000 years, and the arsenic compound arsenic trioxide (ATO) is FDA approved for the treatment…
Researchers at the Georgetown Lombardi Comprehensive Cancer Centre, a part of Georgetown University Medical Centre, have found that an arsenic-based agent already FDA-approved for a…
Scientists at the Johns Hopkins Kimmel Cancer Centre have deciphered the genetic code for medulloblastoma, the most common paediatric brain cancer and a leading killer of children with…
Investigators have demonstrated for the first time that the most common malignant childhood brain tumour, medulloblastoma, is actually several different diseases, each arising from…
Researchers from St. Jude Children's Research Hospital and the Paediatric Brain Tumour Consortium (PBTC) presented at the American Society of Clinical Oncology the findings of a paediatric…
The use of modified measles virus may represent a new treatment for a childhood brain tumour known as medulloblastoma, according to a new study appearing in Neuro-Oncology…
New research from scientists at Queen Mary, University of London shows how the most common type of children's brain cancer can arise from stem cells…
Howard Hughes Medical Institute (HHMI) researchers have identified a new factor that is necessary for the development of many forms of medulloblastoma, the most common type of malignant…
The Hedgehog signalling pathway is involved in a preliminary study and case report describing positive responses to an experimental anticancer drug in a majority of people with advanced…
UCSF scientists have discovered that a tiny filament extending from cells, until recently regarded as a remnant of evolution, may play a role in the most common malignant brain tumour…